Literature DB >> 31633225

MicroRNA-19a attenuates hypoxia-induced cardiomyocyte apoptosis by downregulating NHE-1 expression and decreasing calcium overload.

Jiaqi Ma1, Zhangwei Chen1, Yuanji Ma1, Yan Xia1, Kai Hu1, You Zhou1, Ao Chen1, Juying Qian1, Junbo Ge1.   

Abstract

miR-19a has been shown to be involved in coronary microvascular obstruction injury; however, the underlying molecular mechanisms remain unknown. In our study, we tried to explore the role of miR-19a in cardiomyocyte apoptosis and calcium overload in vivo and in vitro induced by hypoxia. We established the acute myocardial infarction (AMI) rat model by ligating the left anterior descending artery. The expression of miR-19a in the infarct zone of AMI rats and myocardial tissue in the same position in sham rats was analyzed using RT-qPCR while Na(+) /H(+) exchanger 1 (NHE-1) was detected by Western blotting. We also observed the effects of overexpressing miR-19a or administering an NHE-1 inhibitor (cariporide) on hypoxia-induced (HI) calcium overload and apoptosis in primary cardiomyocytes. In addition, dual-luciferase reporter assays were conducted to investigate the potential target of miR-19a on NHE-1. Decreased miR-19a expression, as well as increased apoptosis and NHE-1 expression, were observed in the AMI model. Furthermore, after hypoxia stimulation, miR-19a was gradually reduced as time increased in primary cardiomyocytes. Overexpressing miR-19a using mimics ameliorated the increase in NHE-1 in hypoxic cardiomyocytes and thereby reduced the HI cell calcium overload and cell apoptosis rate from 12.32% to 9.5% (P < .01). In addition, the dual-luciferase reporter gene assay results verified that NHE-1 was the direct target of miR-19a. Our findings suggest that miR-19a activation can attenuate HI cardiomyocyte apoptosis by downregulating NHE-1 expression and decreasing calcium overload.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  NHE-1; apoptosis; calcium overload; cardiomyocytes; hypoxia; microRNA-19a

Mesh:

Substances:

Year:  2019        PMID: 31633225     DOI: 10.1002/jcb.29411

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

Review 1.  MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review.

Authors:  Liuying Chen; Yizhou Xu
Journal:  Front Cardiovasc Med       Date:  2021-11-24

2.  Na+/H+-Exchanger Family as Novel Prognostic Biomarkers in Colorectal Cancer.

Authors:  Xin Zhou; Manman Jiang; Zhihong Liu; Mengmeng Xu; Nannan Chen; Ziyu Wu; Changji Gu; Eugene Chin; Xiaodong Yang
Journal:  J Oncol       Date:  2021-11-01       Impact factor: 4.375

Review 3.  Cell type-specific microRNA therapies for myocardial infarction.

Authors:  Bohao Liu; Bryan Wang; Xiaokan Zhang; Roberta Lock; Trevor Nash; Gordana Vunjak-Novakovic
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.